This page is part of the US Patient Care Summary (US-PCS) Implementation Guide (v1.0.0: STU 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
| Page standards status: Trial-use |
This guide, as well as the artifacts developed by HL7® including terminologies, is produced by HL7 under the terms of HL7® Governance and Operations Manual relating to Intellectual Property (Section 16), specifically its copyright, trademark and patent provisions.
This document is licensed under Creative Commons "No Rights Reserved" (CC0).
HL7®, HEALTH LEVEL SEVEN®, FHIR® and the FHIR
® are trademarks owned by Health Level Seven International, registered with the United States Patent and Trademark Office.
This HL7 specification contains and references intellectual property owned by third parties ("Third Party IP").
Certain examples reference CPT® content. CPT (http://www.ama-assn.org/go/cpt) is copyright © American Medical Association (AMA). All rights reserved. No endorsement by the AMA is intended or implied.
This implementation guide incorporates icons from Font Awesome Free. Font Awesome Free is provided by Fonticons, Inc. under applicable open-source licenses. Font Awesome is a trademark of Fonticons, Inc. For additional information, see https://fontawesome.com/. This implementation guide incorporates icons from Healthicons (https://healthicons.org/). Healthicons are made available under the CC0 public-domain dedication. Images included in this guide are made available under the same terms as the guide noting that HL7®, HEALTH LEVEL SEVEN®, FHIR® and the FHIR
® are trademarks owned by Health Level Seven International, registered with the United States Patent and Trademark Office.
It is the sole responsibility of each organization deploying or testing this specification to ensure their implementations comply with licensing requirements of each Third Party IP. Patients may receive copies of their medical data through US-PCS (see use case) and implementers should anticipate both patient-mediated and provider-mediated exchange when considering Third Party IP use.
Implementers and testers of this specification SHALL abide by the license requirements for each terminology content artifact utilized within a functioning implementation.§ip-1
Terminology licenses SHALL be obtained from the Third Party IP owner for each code system and/or other specified artifact used.§ip-2
Following is a non-exhaustive list of third-party terminologies used in this guide that may require a separate license:
| Terminology | Owner/Contact | Links |
|---|---|---|
| SNOMED CT® | SNOMED International | http://www.snomed.org/snomed-ct/get-snomed-ct |
| SNOMED CT® IPS Terminology | SNOMED International | https://www.snomed.org/international-patient-summary-terminology |
| Logical Observation Identifiers Names & Codes (LOINC®) | Regenstrief Institute, Inc. and the LOINC Committee | https://loinc.org/license/ |
| Unified Codes for Units of Measures (UCUM) | Regenstrief Institute, Inc. and the UCUM Organization | http://unitsofmeasure.org/trac/wiki/TermsOfUse |
| International Classification of Diseases (ICD) classification system | World Health Organization (WHO) | https://www.who.int/publishing/copyright/en/ |
| Anatomical Therapeutic Chemical (ATC) classification system | World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology | https://www.whocc.no/use_of_atc_ddd/ |
| ISO 3166 Country Code | International Organization for Standardization (ISO) | https://www.iso.org/iso-3166-country-codes.html |
| National Drug Code (NDC) [US] | Food and Drug Administration | https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory |
| RxNorm [US] | Unified Medical Language System® (UMLS®) | https://uts.nlm.nih.gov/license.html https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.html |
This publication includes IP covered under the following statements.